Editas Medicine, Inc.EDITNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
0.25
↓ 100% below average
Average (9y)
81.20
Historical baseline
Range
High:433.68
Low:0.25
CAGR
-56.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 0.25 | -97.2% |
| 2023 | 8.89 | -65.7% |
| 2022 | 25.95 | -59.0% |
| 2021 | 63.35 | +43.9% |
| 2020 | 44.04 | -28.9% |
| 2019 | 61.90 | +104.0% |
| 2018 | 30.34 | -63.0% |
| 2017 | 82.02 | +33.2% |
| 2016 | 61.57 | -85.8% |
| 2015 | 433.68 | - |